fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ASH 2012 Report – Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial

Written by | 21 Dec 2012

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.

ASH 2012 Report – Blood levels of immune protein predict risk in Hodgkin disease

Written by | 21 Dec 2012

Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome,

ASH 2012 Report – New multiple myeloma drug shows promise in treating people with advanced disease

Written by | 21 Dec 2012

Therapy may be new option for hard-to-treat blood cancer.

ASH 2012 Report – Potential gene therapy approach to sickle cell disease highlighted at ASH

Written by | 21 Dec 2012

Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.

ASH 2012 Report – New results support bendamustine-rituximab (B-R) combination as first-line treatment in patients with (iNHL) and (MCL)

Written by | 21 Dec 2012

Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.

Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care

Written by | 21 Dec 2012

Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.

Snack attack: Eating unhealthy snack foods may affect cancer risk in patients with Lynch syndrome

Written by | 21 Dec 2012

A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers.

Genomic sequencing data guides treatment of metastatic triple-negative breast cancer patients

Written by | 21 Dec 2012

Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets

CWRU School of Medicine researchers discover new molecule linked to late-stage breast cancer

Written by | 21 Dec 2012

Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.

PRT versus IMRT toxicity in prostate cancer

Written by | 21 Dec 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among  patients with prostate cancer at 12 months post-treatment according to a… read more.

Changes in progenitor cell population in breast may be overlooked factor in breast cancer

Written by | 21 Dec 2012

Research presented at the American Society for Cell Biology (ASCB) annual meeting, 15-19 December 2012, San Francisco.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.